Development and Usability of an Adjustable Prosthesis for Aquatic Therapy
- Disease/Condition
- Amputation
- Drug/Device/Intervention
- Adjustable Aquatic Therapy Prosthesis
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Shirley Ryan AbilityLab
- Location
- Chicago, United States of America
- Phase
- N/A
- Start date
- Aug 23, 2023
- End date
- Dec 31, 2024
- Enrollment
- 3 participants
System Usability Survey - Subject
The initial purpose of this study is to develop a prosthesis which is adjustable to use with
 a variety of patients in aquatic therapy. Aquatic therapy is a beneficial rehabilitation tool
 for individuals with limb loss. The pool environment offloads body weight, which can improve
 comfort on a residual limb and increase confidence in activities outside of the pool. The
 properties of water also assist in strengthening exercises and reducing pain.
 
 Currently, most individuals do not have a prosthesis to use in the pool. Water specific
 prosthesis are often not covered by insurance and can be expensive. For someone that doesn't
 have a water specific prosthesis, they may not be able to do therapy tasks on two legs,
 limiting what activities or exercises can be performed. Through creating an adjustable
 prosthesis, it will allow persons with limb loss to have access to a water specific leg in a
 time efficient, cost effective, and safe manner for rehabilitation.
 
 This study involves a novel prosthesis for use in aquatic therapy. This novel design will
 have an adjustable circumference, residual limb length, and height, allowing a greater number
 of patients to use the prosthesis.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06259695
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06259695 through Pure Global AI's free database. This phase not specified trial is sponsored by Shirley Ryan AbilityLab and is currently Recruitment Completed. The study focuses on Amputation. Target enrollment is 3 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.